Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73
Clinical trial NCT01592214 · COMPLETED
Trial details
- NCT number
- NCT01592214
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2015-08-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.